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Only for ND patients 
Important remarks 
• No guidelines received the rating 1A 
• Only 8 received level 1 recommendations:  
- 4 are grade B (particularly BP goal of < or = 
140/90 mmHg when no albuminuria) 
KDIGO Clinical practice Guideline for the 
management of Blood Pressure in CKD 
Adults 
- CKD ND without Diabetes Mellitus 
- CKD ND with Diabetes Mellitus 
- Kidney Transplantation 
Children 
Elderly 
No discussion on High BP in dialysis 
Management of High BP in CKD 
As in the normal population 
BP < 140/90 mmHg 
BP < 130/80 mmHg 
AASK, MDRD, REIN 
Progression of CKD: role of BP control, Proteinuria and ACEI 
Jafar et al.  Ann Intern Med 2003 
CV protection with lower BP in CKD? 
• AASK: no difference between 141/85 vs 
128/78 mmHg 
• MDRD: no difference between 125/75 vs 
140/90 mmHg 
• REIN 2: no difference between 130/80 vs 
134/82 mmHg 

Influence of kidney function and albuminuria 
on the CV mortality (KDIGO 2013) 
BP <140/90 mmHg 






ADVANCE BP reduction in context: 
UK Prospective Diabetes Study 
UKPDS ADV 




Decrease of the 
CV (15%) and 
renal events         
( 20%) 
The Lancet, Published online 
September 2, 2007 ADVANCE 
ADVANCE: renal protection until 110 mmHg 
JASN 2009 





Chapter 7: Management of HTA in 
elderly CKD 
• Problems of BP determination, GFR estimation, presence of 
comorbidities, vascular goals > renal outcomes 
• Greater importance of SBP 
•  BP Target in uncomplicated patients <140/90 mmHg 
• Benefit for stroke, CHF, not for death! 
Chapter 7: BP management in elderly 
persons with CKD ND 

Conclusions 1 
• A lower target may be chosen in CKD patients 
with proteinuria but after individualized risk-
benefit assessment. 
• The price to pay is a need for a higher number 
of antiHTA drugs and a risk of more frequent 
side-effects. 
Brief discussion after these 
published guidelines 
• What about the variability of BP measurement? 
• What is the best method for accurate BP 
determination?  
• Is there a real evidence-based lower limit for BP 
reduction in CKD ? 
• What about proteinuria and its modification 
during treatment? 
One point which is now well accepted: avoid dual 






Some additional issues from the KDIGO 2012 
guidelines on BP management in CKD 
• What is the best method for accurate BP 
determination in CKD? 
BP measurements in CKD  
(MDRD, AASK, REIN2) 
What is the best method for measuring BP in CKD? 
• ABPM! 
• Home BP 
• Suboptimal management of BP is 
responsible for such evolution 
• Improvement of patient education, 
chronotherapy and use of out-the-office BP 
mesurement to check the real BP control 
during the 24H. 
• We need to develop strategies for achieving 
around-the-clock BP control 


Some additional issues from the KDIGO 2012 
guidelines on BP management in CKD 




Some additional issues from the KDIGO 2012 
guidelines on BP management in CKD 
• What is the importance of albuminuria in the 
management of CKD with high BP? 
 
 
Importance of albuminuria on renal outcome 
Importance of reducing albuminuria on renal outcome 

BP and Hemodialysis 
• BP and the reverse epidemiology 
• Several mechanisms for High BP in HD 
• Quality of BP measurement 
• Target of BP in HD? 
• Optimal treatment? 
43% preHD <140/90 mmHg 




PreHD SBP - Syst 
ABP (mm Hg) SDD r
Weight 
(%)
van de Borne, 1992 13 17 20.9 0.69 1.2%
Elisaf, 1996 12 1 13.9 0.69 2.5%
Huisman, 1995 12 14.3 13.4 0.76 2.7%
Conlon, 2000 31 3.8 20.3 0.69 3.0%
Berns, 1999 28 1.1 18.7 0.69 3.2%
Peixoto, 2000 21 2 15.2 0.69 3.7%
Kooman, 1992 22 13 14.7 0.94 4.1%
Erturk, 1996 40 -3.9 19.6 0.69 4.2%
Nishikimi, 2001 35 21.8 17.3 0.69 4.7%
Cheigh, 1992 53 5.3 20.3 0.69 5.2%
Savage, 1997 27 6.7 14.5 0.69 5.2%
Mitra, 1999 40 17 16.9 0.69 5.7%
Conlon, 1996 35 10.5 15.4 0.67 6.0%
Santos, 2003 71 15 20.4 0.69 6.9%
Canella, 2000 55 16 17.2 0.51 7.5%
Zoccali, 1999 64 5.4 17.5 0.69 8.5%
Agarwal, 2001 67 13.5 17.1 0.70 9.3%
Fagugli, 2002 66 -0.9 12.8 0.69 16.3%
Summary 692 8.3 16.7 Q=129.8, p<0.001 100.0%
      Ambulatory BP More Figure 1
Weighted Mean Difference in BP (mm Hg) (95% CI)
Dialysis Unit More
-40 -20 0 20 40
PreHD systolic BP overestimates ABP 
Agarwal R, et al. CJASN 1: 389-398, 2006 
Is out of dialysis unit BP of 
prognostic value? 
•  Baseline cohort followed for 2 years for 
all-cause mortality. 
• 46 patients (31%) died. 
• Quartiles of systolic BP associated with 
mortality in a Cox model. 
Alborzi P et al CJASN 6: 1228-1243, 2007 







































P=0.999 P=0.182 P=0.228 P=0.339 
“Best home 
BP” 125-




Alborzi P et al CJASN 6: 1228-1243, 2007 
Hypertension control may benefit 
dialysis patients 
• Home BP monitoring should be more routinely used for 
the diagnosis and management of hypertension in 
hemodialysis patients. 
• Epidemiological data suggest that lower BP (<130 mmHg) 
may be linked to mortality and higher BP may not hurt. 
• Randomized trials suggest that lowering BP does not hurt, 
and may in fact help. 
• Adequately powered, RCTs are urgently needed to 
ascertain to what level should the BP be lowered to realize 
cardiovascular benefits in dialysis patients. 
Conclusions 2 
• Confirmation of a high BP level is necessary through 
out-of-the clinic BP measurement 
• In CKD, ABPM offers night-time BP information 
useful for CV and renal risk evaluation. 
• BP variability is a new point to be considered in the 
future. 
• Proteinuria but also other specific risk factors 
(Phosphate, anemia, inflammation,..) should be 
integrated in the management of hypertension in 
CKD 
